The National Organization for the Reform of Marijuana Laws, NORML, announces a new partnership with Curved Papers, Inc. to produce branded rolling papers which are now available online and at select stores nationwide.
Year: 2017
The use of the naturally occurring cannabinoid CBD (cannabidiol) possesses no likely abuse potential and therefore should not be subject to international drug scheduling restrictions, according to recommendations finalized today by the World Health Organization’s Expert Committee on Drug Dependence.
Legal Aid of Western Missouri, an organization that provides free, comprehensive civil legal services to low-income people, can now offer free legal services to indigent defendants charged with marijuana possession.
The use of the naturally occurring cannabinoid CBD is safe, well tolerated, and is not associated with any significant adverse public health effects, according to the findings of a preliminary report compiled by the World Health Organization’s Expert Committee on Drug Dependence. The agency is in the process of considering whether to place CBD within the agency’s international drug scheduling code.
Congressional leadership voted to enact a two-week continuing resolution that maintains present federal spending levels and priorities through December 22, 2017. The resolution extends medical cannabis patient protections imposed by the Rohrabacher-Blumenauer amendment until that date.
Cal NORML has sent comments to state regulators at the CA Department of Food and Agriculture regarding their emergency licensing regulations for cannabis cultivation.
Sales of alcoholic beverages decline following the enactment of medical marijuana access laws, according to a working paper authored by a team of researchers from the University of Connecticut and Georgia State University. Researchers concluded: “States legalizing medical marijuana use experience significant decreases in the aggregate sale of alcohol, beer and wine. Moreover, the effects are not short-lived, with significant reductions observed up to 24 months after the passage of the law.”
Today, sixty-six members of Congress representing both Republicans and Democrats sent a letter to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country.